This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional. (PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acyolethanolamines family of lipid mediators . Features - PEA is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-axylethanolamines famiyl of lipid mediators - PEA Liquid is micronised to a 20um-25um particle size using laser diffraction - Presented in a coconut-derived (MCT) lipid suspension for ease of compounding - 2mL contains 300mg PEA for easy dose calculation - Synthesised from palmitic acid from sustainably sourced palm oil, RSPO certified palm oil - PEA Liquid contains 99% pure PEA, which has been confirmed by purity testing - Low allergen, clean formula. Pleasant natural orange flavour. Ingredients Each 2 mL contains: Palmidrol (Palmitoylethanolamide) 300mg In a base of medium chain triglycerides (fractionated coconut oil), ethanol and cold pressed orange oil. Dosage For extemporaneous compounding by a qualified health professional. Information for compounding: 2mL provides 300mg of palmitoylethanolamide Cautions - Compounding preparations should be supplied to an individual only after consultation with a health professional - It is required that a label is attached to the medicine providing instructions for use for the individuals - Contains ethanol 6% v/v as a preservative - KEEP OUT OF REACH OF CHILDREN - Do not use if seal on cap is broken. - Shake well before use
Related
Related
Related
Related